NEVIRAPINE APOTEX nevirapine 200 mg tablet blister pack

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

nevirapine, Quantity: 200 mg

Commercializzato da:

Arrotex Pharmaceuticals Pty Ltd

INN (Nome Internazionale):

Nevirapine

Forma farmaceutica:

Tablet

Composizione:

Excipient Ingredients: magnesium stearate; lactose; microcrystalline cellulose; crospovidone; copovidone

Via di somministrazione:

Oral

Confezione:

60

Tipo di ricetta:

(S4) Prescription Only Medicine

Indicazioni terapeutiche:

Nevirapine immediate-release tablets in combination with antiretroviral agents are indicated for the treatment of HIV-1 infection in adults and adolescents over the age of 16 years.,Resistant virus emerges rapidly when nevirapine is administered as monotherapy or in dual combination therapy with an antiretroviral agent. Therefore, nevirapine should always be administered in combination with at least two additional antiretroviral agents.

Dettagli prodotto:

Visual Identification: white, oval shaped scored biconvex tablets with engraved "APO" and bisect on one side and "NAV" bisect "200" on the other side; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 24 Months; Container Temperature: Store below 30 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Stato dell'autorizzazione:

Licence status A

Data dell'autorizzazione:

2016-03-17